AAOpt 2024: Takeaways from this year's conference

Eye care providers far and wide came to lecture and learn about the latest innovations in eye care at this year's AAOpt meeting in Indianapolis, Indiana, from November 6-9. The key takeaways from this optometry conference include the exciting advancements in ocular surface treatments and technologies, as well as the ongoing research into the genetics and progression of keratoconus. Several speakers highlighted the wealth of new products and treatments in the pipeline, with Ian Ben Gaddie, OD, FAAO, noting that in a single course, they reviewed 6-7 promising new ocular surface products that will be available in the next 3 years. This speaks to the rapid pace of innovation in the field and the enthusiasm among clinicians about these advancements.

Clark Chang, OD, MSA, MSc, FAAO, discussed an excellent session on the genetics of keratoconus, a topic of great interest given the recent loss of access to a genetic test for the condition in the US market. The presenters have mapped over 200 genes related to keratoconus and are working to develop an improved polygenic risk score. Importantly, they also found that different genes may govern the progression versus the phenotypic expression of the disease, which could help clinicians better monitor and manage their keratoconus patients.

Bill R. Hammond also touched on the growing collaboration between academia and industry, noting that researchers are increasingly working with companies to translate their basic science findings into real-world products and treatments that can improve people's lives. This synergy between the academic and commercial worlds was seen as very positive. Finally, the increasing integration of nutrition and preventative care into optometric education and conferences was highlighted as an encouraging trend, helping to solidify the connection between eye health and overall wellness.

Overall, optometrists conveyed a sense of excitement and optimism about the future of eye care, driven by scientific advancements, cross-disciplinary collaboration, and a focus on holistic patient outcomes.